Christi Shaw serves as Chief Executive Officer of Kite, Gilead's cell therapy company. Based in Santa Monica, California, Christi and her team at Kite are pursuing the ambitious goal of curing cancer as an industry leader in CAR T-cell therapy. In her role, Christi is responsible for Kite’s end-to-end, global cell therapy business. She is driven by values, integrity, and a deep connection to people living with cancer and those who love them. Her leadership has spanned a broad range of therapeutic areas, including oncology, immunology, Alzheimer’s disease, medical devices, and she has been responsible for overseeing the full lifecycle of product portfolios, from discovery and development to commercialization and manufacturing. Before joining Kite, Christi held senior executive positions at Eli Lilly & Co. and Novartis Corp. Christi currently serves on the board of directors of Avantor and the Healthcare Businesswomen’s Association (HBA) and is on the executive committee and the board of directors of the Biotechnology Innovation Organization (BIO). Christi holds a bachelor's degree in business administration from Iowa State University and an MBA from the University of Wisconsin. She resides with her husband and son in Santa Monica, California.